Salbutamol belongs to a group of medicines called short-acting beta-2 receptor agonists, which cause the relaxation of smooth muscle in the airways. It causes the airways to open and thus helps to maintain airway patency. It relieves symptoms of respiratory disorders such as a feeling of tightness in the chest, wheezing, and coughing. The effect of salbutamol occurs after a few minutes and lasts for a short period (4 to 6 hours).
Buventol Easyhaler is indicated for adults and children over 6 years of age for the symptomatic treatment of asthma attacks and asthma exacerbations, as well as for the prevention of asthma attacks caused by physical exertion or expected contact with allergens that usually cause shortness of breath.
In adults, the medicine is also indicated for the symptomatic treatment of exacerbations of chronic obstructive pulmonary disease with reversible airway obstruction.
Before starting treatment with Buventol Easyhaler, the patient should discuss it with their doctor or pharmacist if they have:
If the patient experiences shortness of breath or chest pain, they should consult a doctor.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
In particular, the patient should tell their doctor if they are taking any of the following medicines:
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
The medicine should not be used in pregnant or breastfeeding women, unless the doctor recommends otherwise.
There is no data on the effect of the medicine on the ability to drive and use machines.
The medicine contains a small amount of lactose (milk sugar), which should not cause problems for patients with lactose intolerance. If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
This medicine should always be used as directed by the doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist.
The active substance of the medicine, salbutamol, is in the Easyhaler inhaler. The medicine is a dry powder intended for inhalation through the mouthpiece of the inhaler.
Buventol Easyhaler should be used as needed, and not regularly.
Recommended dose:
Buventol Easyhaler is not indicated for use in children under 6 years of age.
If the patient's asthma is active (e.g., frequent symptoms or exacerbations, such as shortness of breath that interferes with speaking, eating, or sleeping, coughing, wheezing, chest tightness, or limited physical performance), they should immediately tell their doctor, who may initiate treatment or increase the dose of a medicine that helps control asthma symptoms, such as an inhaled corticosteroid.
If the patient thinks the medicine is not working as well as usual, they should tell their doctor as soon as possible (e.g., the patient needs higher doses to relieve breathing problems or asthma symptoms do not improve for at least 3 hours after using the inhaler), as asthma may be worsening and another medicine may be needed.
If the patient uses Buventol Easyhaler more frequently than twice a week to relieve asthma symptoms, not including preventive use before physical exertion, it means that asthma is not well-controlled and may increase the risk of severe asthma attacks (asthma exacerbations), which can cause serious complications and be life-threatening. The patient should contact their doctor as soon as possible to verify their asthma treatment.
If the patient uses a medicine with anti-inflammatory effects in the lungs, such as an "inhaled corticosteroid", every day, it is essential to continue using it regularly, even if the patient feels better.
If the patient thinks the effect of Buventol Easyhaler is too strong or too weak, they should consult their doctor.
Instructions for using the inhaler are at the end of the leaflet.
If a higher dose of the medicine is taken than recommended, it may cause an increased heart rate and a feeling of trembling. These symptoms should resolve on their own within a few hours, but the patient should inform their doctor or pharmacist. Additionally, it may cause a decrease in potassium levels and an increase in glucose in the blood, as well as symptoms suggesting the development of lactic acidosis (increased lactate levels in the blood), such as abdominal pain, increased ventilation (rapid breathing), shortness of breath despite decreased wheezing, cold hands and feet, irregular heartbeat, and increased thirst.
If a dose of Buventol Easyhaler is missed, the patient should take the next dose at the usual time or take the medicine before symptoms of shortness of breath occur. The doctor may recommend taking the medicine regularly every day or only when the patient experiences shortness of breath or shallow breathing. If the patient has any further doubts about using this medicine, they should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
If side effects occur, including any side effects not listed in the leaflet, the patient should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301,
Fax: + 48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Keep out of sight and reach of children.
Store in a temperature below 25 ° C.
Before first use, the medicine should be stored in its original packaging.
After opening the aluminum foil packaging, the medicine should be protected from moisture. It is recommended to store the inhaler in a protective container.
In case of moisture, the inhaler should be replaced with a new one.
The inhaler should be replaced 6 months after opening the packaging. To remember the opening date, it should be written in the box:
Do not use Buventol Easyhaler after the expiry date stated on the packaging after:
Expiry date (EXP). The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Buventol Easyhaler, 200 micrograms/dose:
One metered dose contains 200 micrograms (µg) of salbutamol in the form of salbutamol sulfate 241 µg.
One delivered dose contains 180 micrograms (µg) of salbutamol in the form of salbutamol sulfate 217 µg.
White or almost white powder.
1 Easyhaler inhaler contains 200 doses.
The plastic Easyhaler inhaler is equipped with a mouthpiece and dose counter, packaged in a laminated aluminum foil bag (PET/Al/PE) and placed in a cardboard box.
Pack size:
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
To obtain more detailed information, the patient should contact the representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o.o.
kontakt@orionpharma.info.pl
Detailed and up-to-date information about this product, regarding the use of this medicine, is available by scanning the QR code on the patient leaflet, on the outer packaging of the medicine, and on the inhaler label. The same information is also available on the website: www.oeh.fi/spl
QR code for the website: www.oeh.fi/spl
The Buventol Easyhaler inhaler may differ from inhalers used by the patient in the past.
Therefore, it is very important to use it correctly, as incorrect use may cause the patient not to receive the correct amount of medicine. This may lead to worsening of the patient's condition or inadequate treatment of asthma or COPD (chronic obstructive pulmonary disease).
The doctor, nurse, or pharmacist will show the patient how to use the inhaler correctly.
The patient should make sure they understand how to use the inhaler correctly. If in doubt, they should contact their doctor, nurse, or pharmacist. As with all inhalers, caregivers should ensure that children prescribed Buventol Easyhaler use the correct inhalation technique, as described below. The patient can also use the video instructions at: www.oeh.fi/spl
The Easyhaler inhaler is supplied in a laminated bag. The bag should not be opened until the patient is ready to start treatment, as it helps to keep the powder in the inhaler dry. If the patient is ready to start treatment, they should open the packaging and record the opening date, e.g., in a calendar. The Buventol Easyhaler inhaler can be used for 6 months after removal from the foil bag. | ![]() |
Step 1: SHAKING
| SHAKE 3 TO 5 TIMES![]() | Important information to remember
|
Step 2: CLICKING
| CLICK 1 TIME![]() | Important information to remember
|
before inhaling. |
Step 3: INHALATION
| INHALATION![]() | Important information to remember
|
How to remove powder from the mouthpiece In case of accidental clicking of the inhaler or multiple clicking of the inhaler, or exhaling into the inhaler, the powder should be removed from the mouthpiece:
| ![]() |
The inhaler should be kept dry and clean. If necessary, the mouthpiece of the inhaler can be cleaned with a dry cloth or tissue. Do not use water. The powder in the Easyhaler inhaler is sensitive to moisture.
Using the Easyhaler inhaler in a protective container The inhaler can be used in a protective container, which will increase the product's durability. Before placing the inhaler in the protective container, make sure the mouthpiece cover is covering the mouthpiece, preventing accidental activation of the inhaler. The inhaler can be used without removing it from the protective container. |
Use according to the above instructions, 1. Shaking, 2. Clicking, 3. Inhaling. Remember to: |
| ![]() |
Replacing the Easyhaler inhaler with a new one The inhaler is equipped with a dose counter, which indicates the number of doses remaining. The counter rotates every five activations. When the dose counter changes color to red, it means there are 20 doses left. If the patient does not have a new Easyhaler inhaler, they should contact their doctor to obtain a new prescription. When the counter shows 0, the Easyhaler inhaler should be replaced. If the patient uses a protective container, they should keep it and place the new inhaler in it. | ![]() |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.